88IV - Public company info - Genor Biopharma Holdings Limited

Input the stock code or the company name

Genor Biopharma Holdings Limited, 06998.HK - Cash Flow	2019-12	2018-12
Net Cash Flow from Operating Activities	-111,153	-254,951
Net Cash Flow from Return on Investments & Servicing of Finance	-1,467	-5,485
Interest Received	624	1,557
Interest Paid	-2,091	-7,042
Dividend Received	0	0
Dividend Paid	0	0
Others	0	0
Taxes (Paid) / Refunded	0	0
Net Cash Flow from Investing Activities	-40,677	-29,521
Additions to Fixed Assets	-20,593	-27,637
Disposal of Fixed Assets	0	4
Increase in Investments	-12,730	0
Decrease in Investments	0	0
Net Cash Flow with Related Parties	0	360,042
Others	-7,354	-361,930
Net Cash Flow before Financing Activities	-153,297	-289,957
Net Cash Flow from Financing Activities	280,634	353,973
New Loans	0	0
Loans Repayment	-7,885	-6,649
Fixed Income/Debt Instruments	0	0
Repayment of Fixed Income/Debt Instruments	0	0
Equity Financing	862,911	996,919
Net Cash Flow with Related Parties	0	360,042
Others	-574,392	-996,339
Increase(Decrease) in Cash & Cash Equivalents	127,337	64,016
Cash & Cash Equivalents at Beginning of Year	125,158	61,100
Net Cash Flow due to Change in Exchange Rate/Others	1,025	42
Cash & Cash Equivalents at End of Year	253,520	125,158
Currency	Renminbi	Renminbi
Unit
Auditor's Opinion	0	0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Public company info - Genor Biopharma Holdings Limited , 06998.HK